Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Achieving lipid targets in adults with type 2 diabetes: the Stop Atherosclerosis in Native Diabetics Study.

Russell M, Silverman A, Fleg JL, Lee ET, Mete M, Weir M, Wilson C, Yeh F, Howard BV, Howard WM.

J Clin Lipidol. 2010 Sep-Oct;4(5):435-43. doi: 10.1016/j.jacl.2010.07.007.

PMID:
21076630
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.

Fleg JL, Mete M, Howard BV, Umans JG, Roman MJ, Ratner RE, Silverman A, Galloway JM, Henderson JA, Weir MR, Wilson C, Stylianou M, Howard WJ.

J Am Coll Cardiol. 2008 Dec 16;52(25):2198-205. doi: 10.1016/j.jacc.2008.10.031.

PMID:
19095139
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience.

Mete M, Wilson C, Lee ET, Silverman A, Russell M, Stylianou M, Umans JG, Wang W, Howard WJ, Ratner RE, Howard BV, Fleg JL.

J Diabetes Complications. 2011 Nov-Dec;25(6):362-7. doi: 10.1016/j.jdiacomp.2011.04.001. Epub 2011 Jul 19.

PMID:
21775166
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.

Querton L, Buysschaert M, Hermans MP.

J Clin Lipidol. 2012 Sep-Oct;6(5):434-42. doi: 10.1016/j.jacl.2012.04.002. Epub 2012 Apr 12.

PMID:
23009779
[PubMed - indexed for MEDLINE]
5.

Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .

Wilson C, Huang CC, Shara N, Howard BV, Fleg JL, Henderson JA, Howard WJ, Huentelman H, Lee ET, Mete M, Russell M, Galloway JM, Silverman A, Stylianou M, Umans J, Weir MR, Yeh F, Ratner RE.

J Clin Lipidol. 2010 May-Jun;4(3):165-72. doi: 10.1016/j.jacl.2010.01.008.

PMID:
20563294
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

[Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].

Brath H, Wascher TC, Kästenbauer T, Toplak H.

MMW Fortschr Med. 2012 Jun 28;154 Suppl 2:41-7. German.

PMID:
23424754
[PubMed - indexed for MEDLINE]
7.

Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: a pooled analysis of over 21,000 subjects from 27 clinical trials.

Morrone D, Weintraub WS, Toth PP, Hanson ME, Lowe RS, Lin J, Shah AK, Tershakovec AM.

Atherosclerosis. 2012 Aug;223(2):251-61. doi: 10.1016/j.atherosclerosis.2012.02.016. Epub 2012 Feb 16. Review.

PMID:
22410123
[PubMed - indexed for MEDLINE]
8.

Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome.

Simons L, Tonkon M, Masana L, Maccubbin D, Shah A, Lee M, Gumbiner B.

Curr Med Res Opin. 2004 Sep;20(9):1437-45.

PMID:
15383192
[PubMed - indexed for MEDLINE]
9.

Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.

Howard BV, Roman MJ, Devereux RB, Fleg JL, Galloway JM, Henderson JA, Howard WJ, Lee ET, Mete M, Poolaw B, Ratner RE, Russell M, Silverman A, Stylianou M, Umans JG, Wang W, Weir MR, Weissman NJ, Wilson C, Yeh F, Zhu J.

JAMA. 2008 Apr 9;299(14):1678-89. doi: 10.1001/jama.299.14.1678.

PMID:
18398080
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes.

Rotella CM, Zaninelli A, Le Grazie C, Hanson ME, Gensini GF.

Lipids Health Dis. 2010 Jul 27;9:80. doi: 10.1186/1476-511X-9-80.

PMID:
20663203
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).

Robinson JG, Ballantyne CM, Hsueh W, Rosen J, Lin J, Shah A, Lowe RS, Hanson ME, Tershakovec AM.

J Clin Lipidol. 2011 Nov-Dec;5(6):474-82. doi: 10.1016/j.jacl.2011.06.004. Epub 2011 Jun 15.

PMID:
22108151
[PubMed - indexed for MEDLINE]
13.

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.

Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA; Simvastatin/Thiazolidinedione Study Group.

Clin Ther. 2004 Mar;26(3):379-89.

PMID:
15110130
[PubMed - indexed for MEDLINE]
14.

Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.

Roman MJ, Howard BV, Howard WJ, Mete M, Fleg JL, Lee ET, Devereux RB.

Hypertension. 2011 Sep;58(3):367-71. doi: 10.1161/HYPERTENSIONAHA.111.172486. Epub 2011 Jul 25.

PMID:
21788602
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).

Russell M, Fleg JL, Galloway WJ, Henderson JA, Howard J, Lee ET, Poolaw B, Ratner RE, Roman MJ, Silverman A, Stylianou M, Weir MR, Wilson C, Yeh F, Zhu J, Howard BV.

Am Heart J. 2006 Nov;152(5):867-75.

PMID:
17070147
[PubMed - indexed for MEDLINE]
16.

Can group medical clinics improve lipid management in diabetes?

Crowley MJ, Melnyk SD, Ostroff JL, Fredrickson SK, Jeffreys AS, Coffman CJ, Edelman D.

Am J Med. 2014 Feb;127(2):145-51. doi: 10.1016/j.amjmed.2013.09.027. Epub 2013 Oct 15.

PMID:
24462012
[PubMed - indexed for MEDLINE]
17.

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Kones R.

Drug Des Devel Ther. 2011;5:325-80. doi: 10.2147/DDDT.S14934. Epub 2011 Jun 13. Review.

PMID:
21792295
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Achieving optimal lipid goals in patients with coronary artery disease.

Karalis DG, Subramanya RD, Hessen SE, Liu L, Victor MF.

Am J Cardiol. 2011 Mar 15;107(6):886-90. doi: 10.1016/j.amjcard.2010.11.006. Epub 2011 Jan 19.

PMID:
21247526
[PubMed - indexed for MEDLINE]
19.

Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes.

Guyton JR, Betteridge DJ, Farnier M, Leiter LA, Lin J, Shah A, Johnson-Levonas AO, Brudi P.

Diab Vasc Dis Res. 2011 Apr;8(2):160-72. doi: 10.1177/1479164111406457.

PMID:
21562068
[PubMed - indexed for MEDLINE]
Free Article
20.

Lipid lowering therapy in type 2 diabetes.

Föger B.

Wien Med Wochenschr. 2011 Jun;161(11-12):289-96. doi: 10.1007/s10354-011-0908-4. Review.

PMID:
21769710
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk